Literature DB >> 19692351

Mice defective in Trpm6 show embryonic mortality and neural tube defects.

Roxanne Y Walder1, Baoli Yang, John B Stokes, Patricia A Kirby, Xiao Cao, Peijun Shi, Charles C Searby, Russell F Husted, Val C Sheffield.   

Abstract

The syndrome of hypomagnesemia with secondary hypocalcemia is caused by defective TRPM6. This protein is an ion channel that also contains a kinase in its C-terminus. It is usually diagnosed in childhood and, without treatment with supplemental Mg, affected children suffer from mental retardation, seizures and retarded development. We developed a mouse lacking Trpm6 in order to understand in greater detail the function of this protein. In contrast to our expectations, Trpm6(-/-) mice almost never survived to weaning. Many mice died by embryonic day 12.5. Most that survived to term had neural tube defects consisting of both exencephaly and spina bifida occulta, an unusual combination. Feeding dams a high Mg diet marginally improved offspring survival to weaning. The few Trpm6(-/-) mice that survived were fertile but matings between Trpm6(-/-) mice produced no viable pregnancies. Trpm6(+/-) mice had normal electrolytes except for modestly low plasma [Mg]. In addition, some Trpm6(+/-) mice died prematurely. Absence of Trpm6 produces an apparently different phenotype in mice than in humans. The presence of neural tube defects identifies a previously unsuspected role of Trpm6 in effecting neural tube closure. This genetic defect produces one of very few mouse models of spina bifida occulta. These results point to a critical role of Trpm6 in development and suggest an important role in neural tube closure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19692351      PMCID: PMC2766295          DOI: 10.1093/hmg/ddp392

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  45 in total

1.  Phosphorylation of annexin I by TRPM7 channel-kinase.

Authors:  Maxim V Dorovkov; Alexey G Ryazanov
Journal:  J Biol Chem       Date:  2004-10-12       Impact factor: 5.157

2.  Clinical presentation and outcome in primary familial hypomagnesaemia.

Authors:  H Shalev; M Phillip; A Galil; R Carmi; D Landau
Journal:  Arch Dis Child       Date:  1998-02       Impact factor: 3.791

3.  Targeted oncogene activation by site-specific recombination in transgenic mice.

Authors:  M Lakso; B Sauer; B Mosinger; E J Lee; R W Manning; S H Yu; K L Mulder; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

4.  Familial hypomagnesemia maps to chromosome 9q, not to the X chromosome: genetic linkage mapping and analysis of a balanced translocation breakpoint.

Authors:  R Y Walder; H Shalev; T M Brennan; R Carmi; K Elbedour; D A Scott; A Hanauer; A L Mark; S Patil; E M Stone; V C Sheffield
Journal:  Hum Mol Genet       Date:  1997-09       Impact factor: 6.150

Review 5.  New data on the importance of gestational Mg deficiency.

Authors:  Jean Durlach
Journal:  J Am Coll Nutr       Date:  2004-12       Impact factor: 3.169

6.  Genetic background of HSH in three Polish families and a patient with an X;9 translocation.

Authors:  Reetta Jalkanen; Ewa Pronicka; Henna Tyynismaa; Andre Hanauer; Roxanne Walder; Tiina Alitalo
Journal:  Eur J Hum Genet       Date:  2006-01       Impact factor: 4.246

Review 7.  Essential role for TRPM6 in epithelial magnesium transport and body magnesium homeostasis.

Authors:  Vladimir Chubanov; Thomas Gudermann; Karl P Schlingmann
Journal:  Pflugers Arch       Date:  2005-06-17       Impact factor: 3.657

8.  Novel TRPM6 mutations in 21 families with primary hypomagnesemia and secondary hypocalcemia.

Authors:  Karl P Schlingmann; Martin C Sassen; Stefanie Weber; Ulla Pechmann; Kerstin Kusch; Lutz Pelken; Daniel Lotan; Maria Syrrou; Jeffrey J Prebble; David E C Cole; Daniel L Metzger; Shamima Rahman; Toshihiro Tajima; San-Ging Shu; Siegfried Waldegger; Hannsjoerg W Seyberth; Martin Konrad
Journal:  J Am Soc Nephrol       Date:  2005-08-17       Impact factor: 10.121

9.  Hypomagnesemia with secondary hypocalcemia in a female with balanced X;9 translocation: mapping of the Xp22 chromosome breakpoint.

Authors:  M Chery; V Biancalana; C Philippe; G Malpuech; H Carla; S Gilgenkrantz; J L Mandel; A Hanauer
Journal:  Hum Genet       Date:  1994-05       Impact factor: 4.132

10.  The epithelial Mg2+ channel transient receptor potential melastatin 6 is regulated by dietary Mg2+ content and estrogens.

Authors:  Wouter M Tiel Groenestege; Joost G Hoenderop; Lambertus van den Heuvel; Nine Knoers; René J Bindels
Journal:  J Am Soc Nephrol       Date:  2006-03-08       Impact factor: 10.121

View more
  40 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family.

Authors:  Long-Jun Wu; Tara-Beth Sweet; David E Clapham
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

2.  TRPM6 kinase activity regulates TRPM7 trafficking and inhibits cellular growth under hypomagnesic conditions.

Authors:  Katherine Brandao; Francina Deason-Towne; Xiaoyun Zhao; Anne-Laure Perraud; Carsten Schmitz
Journal:  Cell Mol Life Sci       Date:  2014-05-25       Impact factor: 9.261

Review 3.  Transient receptor potential channels as therapeutic targets.

Authors:  Magdalene M Moran; Michael Allen McAlexander; Tamás Bíró; Arpad Szallasi
Journal:  Nat Rev Drug Discov       Date:  2011-08-01       Impact factor: 84.694

Review 4.  Epithelial transport in inflammatory bowel diseases.

Authors:  Fayez K Ghishan; Pawel R Kiela
Journal:  Inflamm Bowel Dis       Date:  2014-06       Impact factor: 5.325

5.  Uromodulin regulates renal magnesium homeostasis through the ion channel transient receptor potential melastatin 6 (TRPM6).

Authors:  Mingzhu Nie; Manjot S Bal; Jie Liu; Zhufeng Yang; Carolina Rivera; Xue-Ru Wu; Joost G J Hoenderop; René J M Bindels; Denise K Marciano; Matthias T F Wolf
Journal:  J Biol Chem       Date:  2018-08-23       Impact factor: 5.157

6.  Histone phosphorylation by TRPM6's cleaved kinase attenuates adjacent arginine methylation to regulate gene expression.

Authors:  Grigory Krapivinsky; Luba Krapivinsky; Nora E Renthal; Ana Santa-Cruz; Yunona Manasian; David E Clapham
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

Review 7.  Cellular magnesium homeostasis.

Authors:  Andrea M P Romani
Journal:  Arch Biochem Biophys       Date:  2011-05-27       Impact factor: 4.013

Review 8.  Cellular functions of transient receptor potential channels.

Authors:  Daniela Dadon; Baruch Minke
Journal:  Int J Biochem Cell Biol       Date:  2010-04-22       Impact factor: 5.085

9.  Regulation of Mg2+ Reabsorption and Transient Receptor Potential Melastatin Type 6 Activity by cAMP Signaling.

Authors:  Maxime G Blanchard; Wararat Kittikulsuth; Anil V Nair; Jeroen H F de Baaij; Femke Latta; Jonathan R Genzen; Donald E Kohan; René J M Bindels; Joost G J Hoenderop
Journal:  J Am Soc Nephrol       Date:  2015-07-06       Impact factor: 10.121

Review 10.  Phosphoinositide regulation of TRP channels.

Authors:  Tibor Rohacs
Journal:  Handb Exp Pharmacol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.